This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Sasa Bavec: Innovator in Pharmaceutical Formulations
Introduction
Sasa Bavec is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of atorvastatin calcium, a well-known antihypercholesterolemic agent. His work has implications for improving the bioavailability of this important medication.
Latest Patents
Sasa Bavec holds a patent for "Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium." This invention addresses the challenges associated with the solubility of atorvastatin calcium, which can exist in both amorphous and crystalline forms. The patent aims to provide therapeutic equivalence in atorvastatin formulations, regardless of the form used, thereby enhancing the effectiveness of the drug.
Career Highlights
Bavec is associated with Lek Pharmaceuticals D.d., a prominent pharmaceutical company in Slovenia. His work at Lek has focused on developing innovative pharmaceutical formulations that improve drug delivery and efficacy. His expertise in this area has led to advancements in the treatment of cholesterol-related conditions.
Collaborations
Sasa Bavec has collaborated with notable colleagues such as Janez Kerc and Mateja Salobir. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects in pharmaceutical research.
Conclusion
Sasa Bavec's contributions to the field of pharmaceuticals, particularly through his patent on atorvastatin calcium formulations, highlight his role as an innovator in the industry. His work continues to impact the effectiveness of treatments for cholesterol management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile